Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
144M
-
Number of holders
-
90
-
Total 13F shares, excl. options
-
94M
-
Shares change
-
+29.4M
-
Total reported value, excl. options
-
$639M
-
Value change
-
+$220M
-
Put/Call ratio
-
0.04
-
Number of buys
-
61
-
Number of sells
-
-40
-
Price
-
$6.80
Significant Holders of Applied Therapeutics, Inc. - COMMON STOCK (APLT) as of Q1 2024
123 filings reported holding APLT - Applied Therapeutics, Inc. - COMMON STOCK as of Q1 2024.
Applied Therapeutics, Inc. - COMMON STOCK (APLT) has 90 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 94M shares
of 144M outstanding shares and own 65.41% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (10.6M shares), VR Adviser, LLC (9.08M shares), PERCEPTIVE ADVISORS LLC (8.01M shares), JANUS HENDERSON GROUP PLC (6.41M shares), Propel Bio Management, LLC (6.11M shares), Knoll Capital Management, LLC (5.57M shares), Vestal Point Capital, LP (5.11M shares), MORGAN STANLEY (3.19M shares), VANGUARD GROUP INC (3.01M shares), and Simplify Asset Management Inc. (2.82M shares).
This table shows the top 90 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.